ADVERTISEMENT
Why Abbott India Outperformed Pharma Peers
Abbott India gained nearly 32 percent so far this year as the Nifty Pharma Index fell nearly 9 percent.
13 Sep 2019, 07:45 PM IST
Shares of Abbott India Ltd. surged to a record this year outperforming peers as its brands increasingly outsold competitors.The Indian subsidiary of U.S.-based Abbott Laboratories has gained nearly 32 percent so far this year. By comparison, the benchmark Nifty Pharma Index fell nearly 9 percent and most of the drugmaker’s Indian peers declined.The company’s outperformance can be attributed to its brand strength and the complexity in...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Minimal Ad
Experience
Members-Only
Rewards
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT